Hudson Bay Capital Management
CALC icon

Hudson Bay Capital Management’s CalciMedica CALC Stock Holding History

Hudson Bay Capital Management’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-33,371
Closed -$432K – 744
2023
Q3 		$432K Buy
+33,371
New +$553K ﹤0.01% 607

Other funds holding CALC

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Hudson Bay Capital Management's CALC Position: Q4 2023 in Review

Hudson Bay Capital Management sold out of CalciMedica (CALC) in Q4 2023, closing a stake of 33,371 shares — an estimated $432K sold.

Hudson Bay Capital Management first reported a position in CALC in Q3 2023 and held it in 1 quarter. The position peaked at $432K in Q3 2023. 11 funds tracked by Wall St. Rank hold CALC as of Q4 2023.

  • Hudson Bay Capital Management reported no remaining CalciMedica position as of Q4 2023 after selling out during the quarter.
  • Hudson Bay Capital Management sold 33,371 CalciMedica shares in Q4 2023, an estimated $432K.
  • Hudson Bay Capital Management first reported a position in CalciMedica in Q3 2023 and held it in 1 quarter.
  • Hudson Bay Capital Management's CalciMedica position peaked at $432K in Q3 2023.
  • 11 funds tracked by Wall St. Rank held CalciMedica as of Q4 2023.

Based on Hudson Bay Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.